Communiqués Emerald Health Therapeutics, Inc. LIQUIDNET CANADA ATS

Actions

CA29102R1064

Cours en clôture LIQUIDNET CANADA ATS Autres places de cotation			Varia. 5j.	Varia. 1 janv.
- ^INR	-.--%		-.--%	-.--%

2023	C3 Souvenir Holding, Inc. a conclu l'acquisition de Verdelite Sciences, Inc. auprès d'Emerald Health Therapeutics, Inc.	CI
2022	Skye Bioscience, Inc. (OTCPK:SKYE) a complété l'acquisition d'Emerald Health Therapeutics, Inc. (CNSX:EMH) auprès d'Emerald Health Sciences Inc. et autres.	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

CSE Bulletin: Delist - Emerald Health Therapeutics, Inc. (EMH)	11/11/22	NE
IIROC Trading Halt - EMH	09/11/22	AQ
Emerald Health Therapeutics Announces Bridge Loan to Skye Bioscience and Provides Update on Merger	19/10/22	AQ
Emerald Health Therapeutics Receives Court Approval of Plan of Arrangement with Skye Bioscience	29/08/22	AQ
Group of Shareholders Oppose Plan of Arrangement Between Emerald Health Therapeutics and Skye Biosciences Inc.	04/08/22	AQ
Emerald Health Therapeutics Announces Revocation of Management Cease Trade Order	13/07/22	AQ
Emerald Health Therapeutics, Inc. Reports 2022 Q1 Results	12/07/22	AQ
Emerald Health Therapeutics : 2021 Q4	05/07/22	PU
Emerald Health Therapeutics : 2021 - Audited Financial Statements	05/07/22	PU
Emerald Health Therapeutics, Inc. - Reports 2021 Year-end Results and Corporate Update	05/07/22	AQ
Emerald Health Therapeutics, Inc. Transfers US Listing to OTCQB	09/05/22	AQ
Emerald Health Therapeutics : Certification - Interim Filing - CEO	29/11/21	PU
Emerald Health Therapeutics : Certification - Interim Filing - CFO	29/11/21	PU
Emerald Health Therapeutics : 2021 - Q3	29/11/21	PU
Emerald Health Therapeutics : Letter from former auditor	24/11/21	PU
Emerald Health Therapeutics Strategic Licensee, FlowerPod, Unveils Groundbreaking Dose-Controlled Cannabis Vaping Product, New Brand, and U.S. Launch Plans	29/10/21	AQ
Emerald Health Therapeutics : Announces Chief Financial Officer Transition	13/09/21	AQ
Emerald Health Therapeutics : Comments on Board Resignation	12/08/21	AQ
Emerald Health Therapeutics : Hires VP Sales & Marketing	11/08/21	AQ
Emerald Health Therapeutics : Executive Chairman Avtar Dhillon Resigns	09/08/21	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Emerald Health Therapeutics, Inc. LIQUIDNET CANADA ATS

Actions

CA29102R1064

Communiqués

Filtres